NCT07538505

Brief Summary

The goal of this study is to evaluate a Community Health Worker (CHW) program for people living with diabetes in rural areas or locations that are remote from the research team. The study aims to answer the following questions:

  1. 1.Does the CHW program improve diabetes-related health outcomes, such as blood sugar control?
  2. 2.What is the sustainability of the program?
  3. 3.Is the program feasible and acceptable?

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable type-2-diabetes-mellitus

Timeline
68mo left

Started Jun 2026

Longer than P75 for not_applicable type-2-diabetes-mellitus

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 20, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2027

4.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2031

Last Updated

April 20, 2026

Status Verified

April 1, 2026

Enrollment Period

1.3 years

First QC Date

April 13, 2026

Last Update Submit

April 13, 2026

Conditions

Keywords

Community health workersType 2 diabetes mellitusRuralHispanictelehealthmentorlow-incomeimplementationeducationaccess to care

Outcome Measures

Primary Outcomes (1)

  • Change in Hemoglobin A1c (HbA1c)

    Change in glycemic control measured by hemoglobin A1c (HbA1c). HbA1c values will be collected at baseline and follow-up visits. Change will be calculated as the difference between baseline and post-intervention HbA1c levels.

    baseline to 12 months

Secondary Outcomes (5)

  • Change in Blood Pressure

    baseline to 12 months

  • Change in Cholesterol Levels

    baseline to 12 months

  • Change in Body Weight

    baseline to 12 months

  • Change in Body Mass Index (BMI)

    baseline to 12 months

  • Adherence to American Diabetes Association (ADA) Standards of Care

    baseline to 12 months

Study Arms (1)

CHW-led diabetes program

EXPERIMENTAL
Behavioral: Community Health Worker-led diabetes program

Interventions

The intervention consists of four phases: (1) clinic readiness assessment, (2) CHW training, (3) tele-mentoring CHWs to deliver the 12-month diabetes program, and (4) sustainability assessment through 36 months.

CHW-led diabetes program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Self-identified Hispanic Ethnicity
  • Spanish-speaking
  • Type 2 diabetes diagnosis, .g., physician documented diagnosis, HbA1c at least 6.5, treatment with a glucose-lowering agent

You may not qualify if:

  • Condition known to alter HbA1c levels, e.g., recent transfusion, systemic steroids
  • Severe mental illness or cognitive impairment that would preclude participation in group activities
  • Pregnancy during the intervention period
  • Type 1 diabetes mellitus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (8)

  • Vaughan EM, Johnson E, Naik AD, Amspoker AB, Balasubramanyam A, Virani SS, Ballantyne CM, Johnston CA, Foreyt JP. Long-Term Effectiveness of the TIME Intervention to Improve Diabetes Outcomes in Low-Income Settings: a 2-Year Follow-Up. J Gen Intern Med. 2022 Sep;37(12):3062-3069. doi: 10.1007/s11606-021-07363-7. Epub 2022 Feb 7.

    PMID: 35132555BACKGROUND
  • Vaughan EM, Virani S, Al Rifai M, Cardenas VJ Jr, Johnston CA, Porterfield L, Santiago Delgado Z, Samson SL, Schick V, Naik AD. Determining call-to-entry rate and recruitment barriers in clinical studies for community clinics serving low-income populations: a cohort study. BMJ Open. 2023 Oct 28;13(10):e077819. doi: 10.1136/bmjopen-2023-077819.

    PMID: 37898484BACKGROUND
  • Vaughan EM, Cardenas VJ Jr, Chan W, Amspoker AB, Johnston CA, Virani SS, Ballantyne CM, Naik AD. Implementation and Evaluation of a mHealth-Based Community Health Worker Feedback Loop for Hispanics with and at Risk for Diabetes. J Gen Intern Med. 2024 Feb;39(2):229-238. doi: 10.1007/s11606-023-08434-7. Epub 2023 Oct 6.

    PMID: 37803098BACKGROUND
  • Vaughan EM, Naik AD, Amspoker AB, Johnston CA, Landrum JD, Balasubramanyam A, Virani SS, Ballantyne CM, Foreyt JP. Mentored implementation to initiate a diabetes program in an underserved community: a pilot study. BMJ Open Diabetes Res Care. 2021 Aug;9(1):e002320. doi: 10.1136/bmjdrc-2021-002320.

    PMID: 34385148BACKGROUND
  • Vaughan EM, Naik AD, Lewis CM, Foreyt JP, Samson SL, Hyman DJ. Telemedicine Training and Support for Community Health Workers: Improving Knowledge of Diabetes. Telemed J E Health. 2020 Feb;26(2):244-250. doi: 10.1089/tmj.2018.0313. Epub 2019 Mar 6.

    PMID: 30839244BACKGROUND
  • Vaughan EM, Moreno JP, Hyman D, Chen TA, Foreyt JP. Efficacy of oral versus insulin therapy for newly diagnosed diabetes in low-income settings. Arch Gen Intern Med. 2017;1(2):17-22.

    PMID: 29517061BACKGROUND
  • Vaughan EM, Johnston CA, Cardenas VJ, Moreno JP, Foreyt JP. Integrating CHWs as Part of the Team Leading Diabetes Group Visits: A Randomized Controlled Feasibility Study. Diabetes Educ. 2017 Dec;43(6):589-599. doi: 10.1177/0145721717737742. Epub 2017 Oct 19.

    PMID: 29047326BACKGROUND
  • Vaughan EM, Hyman DJ, Naik AD, Samson SL, Razjouyan J, Foreyt JP. A Telehealth-supported, Integrated care with CHWs, and MEdication-access (TIME) Program for Diabetes Improves HbA1c: a Randomized Clinical Trial. J Gen Intern Med. 2021 Feb;36(2):455-463. doi: 10.1007/s11606-020-06017-4. Epub 2020 Jul 22.

    PMID: 32700217BACKGROUND

Related Links

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Elizabeth M. Vaughan, DO, MPH

    University of Texas

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Valeria Lescano Ventura

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2026

First Posted

April 20, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

December 31, 2031

Last Updated

April 20, 2026

Record last verified: 2026-04